Trials / Unknown
UnknownNCT00973037
CYP2D6 Genotype on the Clinical Effect of Tamoxifen
Impact of CYP2D6 Genotype on the Clinical Effects of Tamoxifen Using With Samples From Prospective Randomized Multicenter Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 922 (estimated)
- Sponsor
- Korea University Anam Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the impact of CYP2D6 Genotype on the clinical effects of tamoxifen using with samples from prospective randomized multicenter study(ASTRRA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamoxifen | Tamoxifen 20mg qd |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2009-09-09
- Last updated
- 2009-09-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00973037. Inclusion in this directory is not an endorsement.